	Automatic clear cell renal cell carcinoma grading framework using histopathological images via artificial intelligence: a benchmarking study. BioData Min Song H, Yuan M, Li Z, Wang M, Xu M, Lin H, Lu H, Zhan H, Luan T, Guo C, Fan H, Zhang K, Wang H. PMID: 41620795 [PubMed - as supplied by publisher]
	Treatment Discontinuation in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Lutetium-177 ((177)Lu)-PSMA-617: A Retrospective Real-World Study. Clin Genitourin Cancer Samadi MH, Shamshirgaran A, Sahafi P, Elahifard H, Divband G, Aryana K, Askari E. PMID: 41620317 [PubMed - as supplied by publisher]
	The predictive value of lesion density in enhancing multiparametric MRI for detecting clinically significant prostate cancer. Urol Oncol Khatib A, Al-Daqqaq Z, Black AJ, Chang S, Gleave ME, Mannas MP. PMID: 41619582 [PubMed - as supplied by publisher]
	A Rare Pediatric Paratesticular Spindle Cell Rhabdomyosarcoma and Systematic Literature Review. J Investig Med High Impact Case Rep Arja G, Salloum OH, Jaber J, Jubah T, Alrjoub S, Imran T, Alrjoub A, Hassouneh AWM, Natsheh M. PMID: 41618686 [PubMed - indexed for MEDLINE]
	Efficacy of Photodynamic Diagnosis Is Confined to the Low-Risk Subgroup of Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched Analysis. Int J Urol Abe Y, Taoka R, Kaji A, Harada S, Fujiwara K, Kohashiguchi K, Naito H, Tohi Y, Kato T, Okazoe H, Ueda N, Sugimoto M. PMID: 41618515 [PubMed - indexed for MEDLINE]
	Management of surgical menopause in female patients with bladder cancer undergoing radical cystectomy. Nat Rev Urol Day E, Bizzarri FP, Mackenzie C, Szabados B, Nelson AW, Colquhoun AJ, Perry MJ, Kelly JD, Lobo N. PMID: 41617997 [PubMed - as supplied by publisher]
	Association of the G8 score with urinary continence recovery after robot-assisted radical prostatectomy. World J Urol So SW, Jeong SH, Yuk HD, Ku JH, Kwak C, Han JH, Jeong CW. PMID: 41617913 [PubMed - indexed for MEDLINE]
	Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma. J Immunother Cancer Viray H, M Mantia C, Jegede OA, Atkins MB, Rosenblatt L, Choueiri TK, McDermott DF, Regan MM. PMID: 41617395 [PubMed - indexed for MEDLINE]
	Evaluation of the Safety of Robot-Assisted Radical Cystectomy for Bladder Cancer in Octogenarians. Asian J Endosc Surg Morikawa T, Hamamoto S, Tasaki Y, Ishikawa D, Aoki M, Gonda M, Shimizu N, Nagai T, Etani T, Naiki T, Ando R, Kanemoto K, Okada A, Kawai N, Mogami T, Yasui T. PMID: 41617218 [PubMed - indexed for MEDLINE]
	Associations of fine particulate matter pollution components with overall, prostate cancer, and cardiovascular disease mortality in men with prostate cancer: A cohort study. Environ Res Iyer HS, Perlstein M, Joseph SA, Roscoe C, Zeinomar N, Cole AP, Schumacher FR, Beebe-Dimmer J, Ruterbusch JJ, Wiggins CL, Stroup AM, Schwartz J, Hart JE, Rebbeck TR, Laden F. PMID: 41617107 [PubMed - as supplied by publisher]
	Renal Cell Carcinoma Metastasis to the Pancreas: A Comprehensive Review. J Gastrointest Surg Aziz H, Kotla A, Abbey R, Toliver BC, Gosse M, Yasmine N, Aswani Y, Pawlik T. PMID: 41617051 [PubMed - as supplied by publisher]
	Development of a Prognostic Prediction Model for Clinically Significant Prostate Cancer Based on Lesion Zone and Apparent Diffusion Coefficient Value Quantification. Urology Ashouri R, Reynolds PS, Rajavel S, Hanchate K, Snead W, DiBianco JM, Joseph J, Crispen P, O'Malley P, Grajo JR, Falzarano SM, Stringer TF, Su LM, Weight CJ, Benidir T. PMID: 41616920 [PubMed - as supplied by publisher]
	Impact of tumor location on oncological and perioperative outcomes after robot-assisted radical nephroureterectomy for upper tract urothelial carcinoma. PLoS One Farzat M, Altaie I, Leyh-Bannurah SR, Kachanov M, Wagenlehner FM. PMID: 41615910 [PubMed - indexed for MEDLINE]
	Correction to "Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers". CA Cancer J Clin PMID: 41615696 [PubMed - in process]
	PD-L1 subpopulations of metastatic urothelial carcinoma demonstrate heterogeneity to chemotherapy: an integrated analysis of digitized trial results. Cancer Metastasis Rev Zhou J, Jiang X, Liu Q, Xia HA, Wei P, Hobbs BP. PMID: 41615520 [PubMed - indexed for MEDLINE]
	Water-Related Exposures And Bladder Cancer Risk: A Comprehensive Epidemiological Review. Cancer Epidemiol Biomarkers Prev Bourgi A, Rusch E, Bruyère F. PMID: 41615400 [PubMed - as supplied by publisher]
	Remote delivery of cancer genetic testing in veterans with metastatic prostate cancer: A Million Veteran Program pilot study. Cancer Montgomery B, Lynch JA, Brown J, Maxwell KN, Teerlink CC, Kabilovic N, Stoll K, Simon J, Kogan M, Hassan S, Whitbourne SB, Muralidhar S, Schoen MW, Ramoni R, Gaziano JM, Sokolova AO, Cheng HH, Etzioni R, Pritchard CC. PMID: 41615269 [PubMed - indexed for MEDLINE]
	Investigation of the Correlation Between Selected miRNAs, Proinflammatory Cytokines, and Serum Trace Elements in Bladder Cancer Development and Progression. Curr Issues Mol Biol Ay A, Alkanli N, Atli E, Gurkan H, Koroglu P, Kuvan HC, Ibrahim MH, Cevik G, Sut N. PMID: 41614883 [PubMed]
	A PDCD4-Based Gene Expression Signature Predicts Overall Survival in Renal Cell Carcinoma: A TCGA-Based Discovery and External Validation Study. Curr Issues Mol Biol Suliman BA. PMID: 41614853 [PubMed]
	Compartment-Specific miRNA Levels in Prostate Cancer: InÂ Situ Profiling of Serum Biomarker Candidates. APMIS Wiik EN, Pettersen HS, Skogseth H, Halgunset J, Wibe A. PMID: 41614263 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 175624

Page 1 of 8782



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy